The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Quality of life (QL) is a key outcome for advanced disease cancer patients. The European Organization for Research and Treatment of Cancer (EORTC) has developed the QLQ-C15-PAL questionnaire, a short version of the QLQ-C30 for palliative care. The aim of the present study is to validate the QLQ-C15-PAL for use with Spanish patients with bone metastasis.
For this study, we used a consecutive sample of stage IV cancer patients with bone metastases who started radiotherapy with palliative intention. Two assessments were proposed for each patient: one on the first day of treatment and one a month after the end of the radiotherapy sessions. Psychometric evaluation of the structure, reliability, and validity was undertaken.
One hundred and sixteen patients completed the first questionnaire and seventy five completed the second. Multitrait scaling analysis showed that all items met the standards for convergent validity, and all except the fatigue scale met the standards for divergent validity. Cronbach’s coefficient met the 0.7 alpha criterion on all scales except pain (second assessment). Most QLQ-C15-PAL areas had low-to-moderate correlations with the other areas. Significant differences appeared in the comparisons between groups with regard to: patients who died before the second assessment (six areas); patients receiving chemotherapy before starting radiotherapy in the two assessments (three and four areas, respectively); the performance status in the two assessments (nine and eight areas); and the number of RT sessions received (four). Quality of life was better in the second assessment in nine areas.
The QLQ-C15-PAL is a reliable and valid instrument when applied to a sample of Spanish patients. These results are in line with those of other validation studies.
- Caissie, A., Zeng, L., Nguyen, J., Zhang, L., Jon, F., Dennis, K., et al. (2012). Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases. Clinical Oncology (Royal College of Radiologists), 24(2), 125–133. CrossRef
- Soelver, L., Oestergaard, B., Rydahl-Hansen, S., & Wagner, L. (2012). Advanced cancer patients’ self-assessed physical and emotional problems on admission and discharge from hospital general wards—a questionnaire study. European Journal of Cancer Care (Engl), 21(5), 667–676. CrossRef
- Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., et al. (2006). The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care. European Journal of Cancer, 42(1), 55–64. CrossRef
- Kaasa, S., & Loge, J. H. (2003). Quality of life in palliative care: Principles and practice. Palliative Medicine, 17(1), 11–20. CrossRef
- Lien, K., Zeng, L., Nguyen, J., Cramarossa, G., Culleton, S., Caissie, A., et al. (2011). Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer. Expert Review of Pharmacoeconomics and Outcomes Research, 11(5), 541–547. CrossRef
- Miyazaki, K., Suzukamo, Y., Shimozuma, K., & Nakayama, T. (2012). Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTC QLQ-C15-PAL). Quality of Life Research, 21(2), 335–340. CrossRef
- Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6–9.
- Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of National Cancer Institute, 85(5), 365–376. CrossRef
- Petersen, M. A., Groenvold, M., Aaronson, N., Blazeby, J., Brandberg, Y., de Graeff, A., et al. (2006). Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care. Journal of Clinical Epidemiology, 59(1), 36–44. CrossRef
- Bjorner, J. B., Petersen, M. A., Groenvold, M., Aaronson, N., Ahlner-Elmqvist, M., Arraras, J. I., et al. (2004). Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale. Quality of Life Research, 13(10), 1683–1697. CrossRef
- Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., et al. (2006). EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliative Medicine, 20(2), 59–61. CrossRef
- Taphoorn, M. J., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., et al. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer, 46(6), 1033–1040. CrossRef
- Vivat, B., Young, T., Efficace, F., Sigurdadóttir, V., Arraras, J. I., Asgeirsdóttir, G. H., et al. (2013). Cross-cultural development of the EORTC QLQ-SWB36: A stand-alone measure of spiritual wellbeing for palliative care patients with cancer. Palliative Medicine, 27(5), 457–469. CrossRef
- Cull, A., Sprangers, M., Bjordal, K., Aaronson, N. K., & West, K. (2002). EORTC quality of life group translation procedure (2nd ed.). Brussels: EORTC.
- Karnofsky, D. A., & Burchenal, J. H. (1948). The clinical evaluation of chemotherapeutic agents in cancer. In C. M. McLeod (Ed.), Evaluation of chemotherapeutic agents (pp. 199–205). New York: Colombia University.
- Tabachnik, B. J., & Fidell, L. S. (1993). Using multivariate statistics. London: Harper & Row.
- Ware, J. E., Harris, W. J., Gandek, B., Rogers, B. W., & Reese, P. R. (1997). MAP-R for windows: Multitrait multi-item analysis program—revised user’s guide. Boston: Health Assessment Lab.
- Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297. CrossRef
- Arraras, J. I., Arias, F., Tejedor, M., Pruja, E., Marcos, M., Martínez, E., et al. (2002). The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: Validation study for Spain with head and neck cancer patients. Psychooncology, 11(3), 249–256. CrossRef
- Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998). Using reference data on quality of life–the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). European Journal of Cancer, 34(9), 1381–1389. CrossRef
- Steinmann, D., Schäfer, C., van Oorschot, B., Wypior, H. J., Bruns, F., Bölling, T., et al. (2009). Strahlentherapie und Onkologie, 185(3), 190–197. CrossRef
- Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.
- Middel, B., & Van Sonderen, E. (2002). Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. International Journal of Integrated Care, 2(17), 1–18.
- Caissie, A., Nguyen, J., Chen, E., Zhang, L., Sahgal, A., Clemons, M., et al. (2012). Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL. International Journal of Radiation Oncology Biology Physics, 83(4), 1238–1245. CrossRef
- Hermann, K., Engeser, P., Szecsenyi, J., & Miksch, A. (2012). Palliative patients cared for at home by PAMINO-trained and other GPs. Health-related quality of life as measured by QLQ-C15-PAL and POS. BioMed Central Palliative Care, 11(1), 13. CrossRef
- Shin, K., Zeng, L., Chen, E., Zhang, L., Culleton, S., Dennis, K., et al. (2012). Do elderly patients with metastatic cancer have worse quality of life scores? Supportive Care in Cancer, 20(9), 2121–2127. CrossRef
- Suárez-del-Real, Y., Allende-Pérez, S., Alférez-Mancera, A., Rodríguez, R. B., Jiménez-Toxtle, S., Mohar, A., et al. (2001). Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care. Psychooncology, 20(8), 889–896. CrossRef
- Caissie, A., Culleton, S., Nguyen, J., Zhang, L., Zeng, L., Holden, L., et al. (2012). EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Supportive Care in Cancer, 20(4), 841–848. CrossRef
- Koo, K., Zeng, L., Chen, E., Zhang, L., Culleton, S., Dennis, K., et al. (2012). Do elderly patients with metastatic cancer have worse quality of life scores? Supportive Care in Cancer, 20(9), 2121–2127. CrossRef
- Steinmann, D., Paelecke-Habermann, Y., Geinitz, H., Aschoff, R., Bayerl, A., Bölling, T., et al. (2012). Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BioMed Central Cancer, 10(12), 283.
- The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients
Quality of Life Research
Volume 23, Issue 3 , pp 849-855
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Quality of life
- Advanced disease
- Industry Sectors
- Author Affiliations
- 1. Radiotherapeutic Oncology Department, Complejo Hospitalario de Navarra, Irunlarrea 3, 31008, Pamplona, Spain
- 2. Medical Oncology Department, Complejo Hospitalario de Navarra, Irunlarrea 3, 31008, Pamplona, Spain
- 3. Fundación Miguel Servet, NavarraBiomed, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Pamplona, Spain